Can Phosphodiesterase Type 5 Inhibitors Cure Erectile Dysfunction?
- 30 June 2006
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 49 (6) , 979-986
- https://doi.org/10.1016/j.eururo.2005.12.055
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Chronic Treatment with Tadalafil Improves Endothelial Function in Men with Increased Cardiovascular RiskEuropean Urology, 2005
- Sildenafil Prevents Endothelial Dysfunction Induced by Ischemia and Reperfusion via Opening of Adenosine Triphosphate–Sensitive Potassium ChannelsCirculation, 2005
- 118 Curing erectile dysfunction — long term effects of taking PDE-5-inhibitors on a daily basisEuropean Urology Supplements, 2004
- Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular diseaseInternational Journal of Cardiology, 2002
- The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemiaJournal of the American College of Cardiology, 2002
- The effect of sildenafil on nitric oxide–mediated vasodilation in healthy menClinical Pharmacology & Therapeutics, 2001
- Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failureJournal of the American College of Cardiology, 2000
- Early Endothelial Dysfunction Predicts the Development of Transplant Coronary Artery Disease at 1 Year PosttransplantCirculation, 1996
- Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury.Circulation, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993